16739A032302-ASPIRE-NCT06931340OpenA032302: Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)A32302 (ASPIRE)NCT06931340NationalAdultTreatmentIIIGlobalProstateRapisuwon, SutheeGeorgetown University Medical Center : Alan Zwart; Lombardi Comprehensive Cancer Center : Alan Zwart; MedStar Health and GUMC; Medstar Washington Hospital Center : Felobateer HannaGenito-urinaryOncology GroupMHRI Washington Cancer Institute16794Felobateer HannaFelobateer Hannafelobateer.a.hanna@medstar.net16795Alan ZwartAlan Zwartaz6@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">&copy; 2026 Advarra, Inc.</a>